ArticleRheumatology international2020

Interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) axis in idiopathic inflammatory myopathies and its association with laboratory and clinical parameters: a pilot study.

Aleksandra Opinc et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.